The controlling shareholder of CONCORD HC GP, Beijing Taihe Cheng, pledged 35.6 million H shares, accounting for 4.54% of the total share capital
The controlling shareholder of CONCORD HC GP, Beijing Taihecheng Medical Technology Co., Ltd., has pledged 35.6 million H shares, accounting for 4.54% of the company's total share capital. The pledge is for the benefit of Shanghai Pudong Development Bank, and Beijing Taihecheng directly holds approximately 99.99% of the company's shares
According to the announcement from CONCORD HC GP (02453), on August 26, 2025, the company's controlling shareholder (as defined in the listing rules), Beijing Taihecheng Medical Technology Co., Ltd. (Beijing Taihecheng), agreed to pledge 35.6 million H shares of the company to Shanghai Pudong Development Bank as the beneficiary, which accounts for approximately 99.99% of the total shares directly held by Beijing Taihecheng. As of the date of this announcement, the H shares pledged by Beijing Taihecheng account for approximately 4.54% of the company's total issued shares.
As far as the directors are aware, Shanghai Pudong Development Bank is an independent third party to the company and its related parties
